List of Epizyme patents

Patents where

Current Assignee

Name

Epizyme

Name	Description	Patent Applicant	Current Assignee	Patent Jurisdiction	Patent Number	Date of Patent
‌ US Patent 11572383 Methods of synthesizing substituted purine compounds		Epizyme	Epizyme	United States Patent and Trademark Office	11572383	February 7, 2023
‌ US Patent 9718816 1-phenoxy-3-(alkylamino)-propan-2-ol derivatives as CARM1 inhibitors and uses thereof	Patent 9718816 was granted and assigned to Epizyme on August, 2017 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9718816	August 1, 2017
‌ US Patent 8691507 Inhibitors of human EZH2 and methods of use thereof	Patent 8691507 was granted and assigned to Epizyme on April, 2014 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	8691507	April 8, 2014
‌ US Patent 9175331 Inhibitors of human EZH2, and methods of use thereof	Patent 9175331 was granted and assigned to Epizyme on November, 2015 by the United States Patent and Trademark Office.		Epizyme	United States Patent and Trademark Office	9175331	November 3, 2015
‌ US Patent 11052093 Aryl-or heteroaryl-substituted benzene compounds	Patent 11052093 was granted and assigned to Epizyme on July, 2021 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	11052093	July 6, 2021
‌ US Patent 9333217 Inhibitors of human EZH2, and methods of use thereof	Patent 9333217 was granted and assigned to Epizyme on May, 2016 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9333217	May 10, 2016
‌ US Patent 9334527 Inhibitors of human EZH2, and methods of use thereof	Patent 9334527 was granted and assigned to Epizyme on May, 2016 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9334527	May 10, 2016
‌ US Patent 11642346 Combination therapy for treating cancer	Patent 11642346 was granted and assigned to Epizyme on May, 2023 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	11642346	May 9, 2023
‌ US Patent 11672800 Combination therapies with EHMT2 inhibitors	Patent 11672800 was granted and assigned to Epizyme on June, 2023 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	11672800	June 13, 2023
‌ US Patent 10266526 Substituted 1,2,3-triazoles as SMYD inhibitors for treating cancer	Patent 10266526 was granted and assigned to Epizyme on April, 2019 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	10266526	April 23, 2019
‌ US Patent 9738651 CARM1 inhibitors and uses thereof	Patent 9738651 was granted and assigned to Epizyme on August, 2017 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9738651	August 22, 2017
‌ US Patent 10039748 PRMT1 inhibitors and uses thereof	Patent 10039748 was granted and assigned to Epizyme on August, 2018 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	10039748	August 7, 2018
‌ US Patent 11642348 Substituted benzene compounds	Patent 11642348 was granted and assigned to Epizyme on May, 2023 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	11642348	May 9, 2023
‌ US Patent 9732041 Arginine methyltransferase inhibitors and uses thereof	Patent 9732041 was granted and assigned to Epizyme on August, 2017 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9732041	August 15, 2017
‌ US Patent 9090562 Aryl- or heteroaryl-substituted benzene compounds	Patent 9090562 was granted and assigned to Epizyme on July, 2015 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9090562	July 28, 2015
‌ US Patent 9447079 PRMT1 inhibitors and uses thereof	Patent 9447079 was granted and assigned to Epizyme on September, 2016 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9447079	September 20, 2016
‌ US Patent 9532992 Substituted benzene compounds	Patent 9532992 was granted and assigned to Epizyme on January, 2017 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9532992	January 3, 2017
‌ US Patent 9045455 Arginine methyltransferase inhibitors and uses thereof	Patent 9045455 was granted and assigned to Epizyme on June, 2015 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9045455	June 2, 2015
‌ US Patent 10463671 Combination therapy for treating cancer	Patent 10463671 was granted and assigned to Epizyme on November, 2019 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	10463671	November 5, 2019
‌ US Patent 9023883 PRMT1 inhibitors and uses thereof	Patent 9023883 was granted and assigned to Epizyme on May, 2015 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9023883	May 5, 2015
‌ US Patent 11633420 Method of treating leukemia	Patent 11633420 was granted and assigned to Epizyme on April, 2023 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	11633420	April 25, 2023
‌ US Patent 9365519 PRMT5 inhibitors and uses thereof	Patent 9365519 was granted and assigned to Epizyme on June, 2016 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9365519	June 14, 2016
‌ US Patent 8993555 PRMT5 inhibitors and uses thereof	Patent 8993555 was granted and assigned to Epizyme on March, 2015 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	8993555	March 31, 2015
‌ US Patent 9522152 Aryl- or heteroaryl-substituted benzene compounds	Patent 9522152 was granted and assigned to Epizyme on December, 2016 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9522152	December 20, 2016
‌ US Patent 9549931 Aryl- or heteroaryl-substituted benzene compounds	Patent 9549931 was granted and assigned to Epizyme on January, 2017 by the United States Patent and Trademark Office.	Epizyme	Epizyme	United States Patent and Trademark Office	9549931	January 24, 2017

...

Results per page:

137 results

0 selected

137 results

0 selected